Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FJJ18
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,192
Award facts
- Contract value 100% obligated
- $25,192.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,192.30 delivery order to AmerisourceBergen Drug Corp for Menveо 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract, which was not set-aside, carries a firm fixed price structure and was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The product will be delivered to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in the federal medical procurement supply chain, particularly through its relationship with the Defense Logistics Agency and the Defense Health Agency. The company's federal contract portfolio demonstrates its capability to supply critical medical commodities including specialty medications, vaccines, and medical devices across multiple therapeutic domains to military and veteran healthcare systems. This specific vaccine delivery order reflects the ongoing demand for immunization products within the federal healthcare system and underscores AmerisourceBergen's role as a primary vendor for time-sensitive pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DB25FJJ18?
SPE2DB25FJJ18 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FJJ18 worth?
The government has obligated $25,192 on SPE2DB25FJJ18.
Is contract SPE2DB25FJJ18 an order under another contract?
Yes. SPE2DB25FJJ18 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJJ18 competed?
The extent of competition for SPE2DB25FJJ18 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award